Moderna Inc. (MRNA)
NASDAQ: MRNA
· Real-Time Price · USD
28.79
0.42 (1.48%)
At close: Oct 03, 2025, 2:34 PM
1.48% (1D)
| Bid | 27.11 |
| Market Cap | 11.2B |
| Revenue (ttm) | 3.06B |
| Net Income (ttm) | -2.9B |
| EPS (ttm) | -8.46 |
| PE Ratio (ttm) | -3.4 |
| Forward PE | -3.7 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 30.13 |
| Volume | 5,627,679 |
| Avg. Volume (20D) | 10,312,292 |
| Open | 28.65 |
| Previous Close | 28.37 |
| Day's Range | 27.91 - 28.99 |
| 52-Week Range | 23.15 - 62.11 |
| Beta | 2.01 |
| Ex-Dividend Date | n/a |
About MRNA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MRNA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MRNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsModerna Inc. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+4.02%
Moderna shares are trading higher. The company rep...
Unlock content with
Pro Subscription
3 weeks ago
-7.4%
Vaccine stocks are trading lower after a report indicating that Trump administration officials plan to link child deaths to COVID-19 vaccines.
1 week ago · accessnewswire.com
Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UKThe Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK population The facility marks a...
